Politics By Mark Sherman and Jessica Gresko — Associated Press Supreme Court skeptical of Biden’s workplace vaccine rule
Health By Joanne Silberner Pushback to Covid-19 vaccines remains stubbornly high among white evangelicals
The Readout LOUD By Damian Garde, Meg Tirrell and Adam Feuerstein Listen: Biotech in 2022, the Omicron surge, & the Elizabeth Holmes verdict
Pharmalot By Ed Silverman Chilean health ministry is urged to issue a compulsory license for the Pfizer Covid pill
Pharmalot By Ed Silverman Institutional investors urge pharma boards to tie executive compensation to global Covid vaccine equity
First Opinion By Elliott J. Millenson Containing Covid-19 requires rapid tests that are highly sensitive to infections. Why is the FDA asking for something different?
Health By Matthew Herper Study raises doubts about rapid Covid tests’ reliability in early days after infection
First Opinion By Gregory D. Stevens ‘Protect our hospitals’ might convince Britons to get Covid-19 vaccines, but it won’t work in the U.S.
First Opinion By Jeremy Menchik Confessions of a ‘human guinea pig’: Why I’m resigning from Moderna vaccine trials
Don't Miss By STAT Staff We wish we’d written that: STAT staffers share their favorite stories of 2021
Pharmalot By Ed Silverman STAT/Harris Poll: Vaccinated Americans far more likely to take Pfizer Covid-19 pill than unvaccinated people
Health By Megan Molteni Forecasting the Omicron winter: Experts envision various scenarios, from bad to worse
Biotech By Matthew Herper FDA authorizes Merck’s Covid-19 pill, but stresses its use should be limited
First Opinion By Vinay Prasad At a time when the U.S. needed Covid-19 dialogue between scientists, Francis Collins moved to shut it down
Health By Nicholas Florko Top regulator says need for Omicron vaccine depends on staying power of variant
First Opinion By Duane Schulthess An Omicron oddity: The number of cases doesn’t predict the number of deaths
Health By Helen Branswell A computational biologist weighs in on Omicron, the future of vaccines, and the CDC’s variant forecast
